Flagship Pioneering Announces Two New Agreements With Ampersand Biomedicines and Montai Therapeutics Under Its Strategic Partnership With Pfizer

PR NewswireNov 20 06:30 ET

Foghorn Therapeutics (FHTX) Collaborates With Eli Lilly and Surpasses Q3 Expectations

TipRanksNov 13 05:47 ET

Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences

GlobeNewswireNov 12 07:54 ET

Express News | Foghorn Therapeutics Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results

BenzingaNov 5 15:51 ET

H.C. Wainwright Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 5 06:36 ET · Ratings

TD Cowen Maintains Foghorn Therapeutics(FHTX.US) With Buy Rating

Moomoo NewsNov 4 19:33 ET · Ratings